HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infliximab eye drops treatment in corneal neovascularization.

Abstract
Corneal neovascularization is a serious condition that may arise secondary to chemical burns, ischemia, infection, trauma, and inflammation and represents a major cause of blindness. This study investigated the efficacy of topical application of infliximab [tumor necrosis factor-a (TNF-a) monoclonal antibody] in the treatment of corneal neovascularization in the rabbit model.
AuthorsO B Voiculescu, L M Voinea
JournalJournal of medicine and life (J Med Life) 2015 Oct-Dec Vol. 8 Issue 4 Pg. 566-7 ISSN: 1844-3117 [Electronic] Romania
PMID26664491 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkalies
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Ophthalmic Solutions
  • Infliximab
Topics
  • Alkalies (chemistry)
  • Angiogenesis Inhibitors (therapeutic use)
  • Animals
  • Antibodies, Monoclonal (therapeutic use)
  • Corneal Neovascularization (drug therapy, pathology)
  • Infliximab (therapeutic use)
  • Ophthalmic Solutions (therapeutic use)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: